Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Fagron Compounding Services
WARNING LETTER
•Fagron Compounding Services•September 21, 2016

Fagron Compounding Services – FDA Warning Letter, Sep 21, 2016

Record Details

The FDA issued a Warning Letter to Fagron Compounding Services, LLC dba Fagron Sterile Services following an inspection from August 29 to September 21, 2016. The facility, registered as an outsourcing facility, was found to have serious deficiencies in producing sterile drug products, rendering them adulterated under section 501(a)(2)(B) of the FDCA due to CGMP violations.

Key violations include: 1. Failure to establish and follow adequate written responsibilities and procedures for the quality control unit (21 CFR 211.22(d)). 2. Failure to thoroughly investigate unexplained discrepancies or batch failures (21 CFR 211.192). 3. Failure to conduct appropriate laboratory determination of satisfactory conformance to final specifications for drug products prior to release (21 CFR 211.165(a)).

The FDA found the company's October 7, 2016, response to the Form FDA 483 inadequate. Specifically, the response regarding the review of building management system (BMS) alarms was insufficient, lacking a clear rationale for critical vs. non-critical alarms and an updated BMS procedure. Other corrective actions, such as revised SOPs for visual inspection and product release (including post-use filter integrity testing), could not be fully evaluated due to a lack of supporting documentation.

The FDA emphasized that the company

Company
Fagron Compounding Services
Inspection date
September 21, 2016
Product type
Drugs
Office
Detroit District Office
People
  • Art O. Czabaniuk (Program Division Director)
  • Hans Stoles
View Company Profile

ID · 6c4195bc-2404-4702-b806-210cc38ec114

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 353b21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 U.S.C. 331(k)21 CFR 211.22(d)21 CFR 211.192

Full citation text and observation details available on the Dashboard.

Other documents for Fagron Compounding Services
  • 483 - 2025-08-08August 8, 2025
  • 483 - 2024-06-28June 28, 2024
  • WARNING_LETTER - 2024-06-28June 28, 2024
  • 483 - 2022-03-24March 24, 2022
  • EIR - 2022-03-24March 24, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Fagron Compounding Services
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.